{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-24-000770","form_type":"8-K","ticker":"TENX","cik":"0000034956","company_name":"TENAX THERAPEUTICS, INC.","filed_at":"2024-01-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.570131+00:00","generated_at":"2026-06-06T21:33:19.956833+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Tenax Therapeutics regains compliance with Nasdaq minimum bid price rule","bullets":["Received Nasdaq written confirmation on Jan 18, 2024, after 10 consecutive trading days (Jan 3-17) closing at $1.00 or greater.","Originally notified of bid price deficiency on March 29, 2023; later granted extension through March 25, 2024.","Compliance achieved ahead of extension deadline; delisting risk removed.","Bid Price Rule (Nasdaq Listing Rule 5550(a)(2)) matter now closed."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-24-000770","json":"https://secwatch.observer/filing/0001654954-24-000770.json","markdown":"https://secwatch.observer/filing/0001654954-24-000770.md","text":"https://secwatch.observer/filing/0001654954-24-000770.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/34956/000165495424000770/0001654954-24-000770-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/34956/000165495424000770/tenx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T21:33:19.956833+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}